000182334 001__ 182334
000182334 005__ 20241220120852.0
000182334 0247_ $$2doi$$a10.1002/ijc.34337
000182334 0247_ $$2pmid$$apmid:36305646
000182334 0247_ $$2ISSN$$a0020-7136
000182334 0247_ $$2ISSN$$a1097-0215
000182334 0247_ $$2altmetric$$aaltmetric:137819285
000182334 037__ $$aDKFZ-2022-02577
000182334 041__ $$aEnglish
000182334 082__ $$a610
000182334 1001_ $$0P:(DE-He78)16b8745cffb0db0d366978d3afe17ebc$$aManoochehri, Mehdi$$b0$$eFirst author
000182334 245__ $$aDNA methylation biomarkers for non-invasive detection of triple negative breast cancer using liquid biopsy.
000182334 260__ $$aBognor Regis$$bWiley-Liss$$c2023
000182334 3367_ $$2DRIVER$$aarticle
000182334 3367_ $$2DataCite$$aOutput Types/Journal article
000182334 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1691142620_20938$$xReview Article
000182334 3367_ $$2BibTeX$$aARTICLE
000182334 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000182334 3367_ $$00$$2EndNote$$aJournal Article
000182334 500__ $$a#EA:B070#EA:B072#LA:B070#LA:B072# / 2023 Mar 1;152(5):1025-1035
000182334 520__ $$aNon-invasive detection of aberrant DNA methylation could provide invaluable biomarkers for earlier detection of triple negative breast cancer (TNBC) which could help clinicians with easier and more efficient treatment options. We evaluated genome-wide DNA methylation data derived from TNBC and normal breast tissues, peripheral blood of TNBC cases and controls, and reference samples of sorted blood and mammary cells. Differentially methylated regions (DMRs) between TNBC and normal breast tissues were stringently selected, verified, and externally validated. A machine-learning algorithm was applied to select the top DMRs, which then were evaluated on plasma-derived circulating cell-free DNA (cfDNA) samples of TNBC patients and healthy controls. We identified 23 DMRs accounting for the methylation profile of blood cells and reference mammary cells and then selected six top DMRs for cfDNA analysis. We quantified un-/methylated copies of these DMRs by droplet digital PCR analysis in a plasma test set from TNBC patients and healthy controls and confirmed our findings obtained on tissues. Differential cfDNA methylation was confirmed in an independent validation set of plasma samples. A methylation score combining signatures of the top three DMRs overlapping with the SPAG6, LINC10606, and TBCD/ZNF750 genes had the best capability to discriminate TNBC patients from controls (AUC=0.78 in the test set and AUC=0.74 in validation set). Our findings demonstrate the usefulness of cfDNA-based methylation signatures as non-invasive liquid biopsy markers for the diagnosis of TNBC. This article is protected by copyright. All rights reserved.
000182334 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000182334 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000182334 650_7 $$2Other$$aBiomarker
000182334 650_7 $$2Other$$aDNA methylation
000182334 650_7 $$2Other$$aLiquid biopsy
000182334 650_7 $$2Other$$aNon-invasive detection
000182334 650_7 $$2Other$$aTriple Negative Breast Cancer
000182334 7001_ $$0P:(DE-He78)0659c0184321ffbb893a3306e199f67e$$aBorhani, Nasim$$b1
000182334 7001_ $$0P:(DE-He78)3c4679d03b730156fae20c4948722efe$$aGerhäuser, Clarissa$$b2$$udkfz
000182334 7001_ $$0P:(DE-He78)45a6854ecf41ba2e65ca3ba0d560f14c$$aAssenov, Yassen$$b3
000182334 7001_ $$0P:(DE-He78)7f52f75aab723501c520280cebdb2c46$$aSchönung, Maximilian$$b4$$udkfz
000182334 7001_ $$0P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aHielscher, Thomas$$b5$$udkfz
000182334 7001_ $$aChristensen, Brock C$$b6
000182334 7001_ $$aLee, Min Kyung$$b7
000182334 7001_ $$aGröne, Hermann-Josef$$b8
000182334 7001_ $$0P:(DE-He78)c403a040c97f91902a7d31b93859f9fc$$aLipka, Daniel$$b9$$udkfz
000182334 7001_ $$aBrüning, Thomas$$b10
000182334 7001_ $$00000-0001-7531-2736$$aBrauch, Hiltrud$$b11
000182334 7001_ $$aKo, Yon-Dschun$$b12
000182334 7001_ $$0P:(DE-He78)537e07b3e57b16c7b214fc2242e4326b$$aHamann, Ute$$b13$$eLast author$$udkfz
000182334 773__ $$0PERI:(DE-600)1474822-8$$a10.1002/ijc.34337$$gp. ijc.34337$$n5$$p1025-1035$$tInternational journal of cancer$$v152$$x0020-7136$$y2023
000182334 8767_ $$82022 (V10366)$$92022-06-23$$d2024-12-19$$eHybrid-OA$$jZahlung erfolgt
000182334 909CO $$ooai:inrepo02.dkfz.de:182334$$pVDB$$pOpenAPC$$popenCost
000182334 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)16b8745cffb0db0d366978d3afe17ebc$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000182334 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0659c0184321ffbb893a3306e199f67e$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000182334 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3c4679d03b730156fae20c4948722efe$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000182334 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)45a6854ecf41ba2e65ca3ba0d560f14c$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000182334 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7f52f75aab723501c520280cebdb2c46$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000182334 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000182334 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c403a040c97f91902a7d31b93859f9fc$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000182334 9101_ $$0I:(DE-588b)2036810-0$$60000-0001-7531-2736$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000182334 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)537e07b3e57b16c7b214fc2242e4326b$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000182334 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000182334 9141_ $$y2022
000182334 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2021-02-04$$wger
000182334 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-04
000182334 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-02-04
000182334 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-04
000182334 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-21$$wger
000182334 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000182334 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000182334 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000182334 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000182334 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000182334 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-21
000182334 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINT J CANCER : 2022$$d2023-10-21
000182334 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bINT J CANCER : 2022$$d2023-10-21
000182334 915pc $$0PC:(DE-HGF)0000$$2APC$$aAPC keys set
000182334 915pc $$0PC:(DE-HGF)0001$$2APC$$aLocal Funding
000182334 9202_ $$0I:(DE-He78)B072-20160331$$kB072$$lMolekulargenetik des Mammakarzinoms$$x0
000182334 9202_ $$0I:(DE-He78)B070-20160331$$kB070$$lB070 Funktionelle Genomanalyse$$x1
000182334 9201_ $$0I:(DE-He78)B370-20160331$$kB370$$lEpigenomik$$x0
000182334 9201_ $$0I:(DE-He78)B072-20160331$$kB072$$lMolekulargenetik des Mammakarzinoms$$x1
000182334 9201_ $$0I:(DE-He78)B340-20160331$$kB340$$lTranslationale Medizinische Onkologie$$x2
000182334 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x3
000182334 9201_ $$0I:(DE-He78)TU01-20160331$$kTU01$$lDKTK Koordinierungsstelle Tübingen$$x4
000182334 9200_ $$0I:(DE-He78)B072-20160331$$kB072$$lMolekulargenetik des Mammakarzinoms$$x0
000182334 9200_ $$0I:(DE-He78)B070-20160331$$kB070$$lB070 Funktionelle Genomanalyse$$x1
000182334 980__ $$ajournal
000182334 980__ $$aVDB
000182334 980__ $$aI:(DE-He78)B370-20160331
000182334 980__ $$aI:(DE-He78)B072-20160331
000182334 980__ $$aI:(DE-He78)B340-20160331
000182334 980__ $$aI:(DE-He78)C060-20160331
000182334 980__ $$aI:(DE-He78)TU01-20160331
000182334 980__ $$aUNRESTRICTED
000182334 980__ $$aAPC